Darwin Global Management, Ltd. - Feb 27, 2023 Form 4 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
10%+ Owner
Signature
Darwin Global Management, Ltd. By: /s/ John Legge, Director and Chief Financial Officer
Stock symbol
AMAM
Transactions as of
Feb 27, 2023
Transactions value $
$24,094,937
Form type
4
Date filed
3/8/2023, 09:51 AM
Previous filing
Mar 8, 2023
Next filing
Jun 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMAM American Depository Shares ("ADSs") Purchase $357K +65.1K +0.86% $5.48 7.65M Feb 27, 2023 Ordinary Shares 456K $0.00 See footnotes F1, F2, F3
transaction AMAM ADSs Purchase $241K +40K +0.52% $6.02 7.69M Feb 28, 2023 Ordinary Shares 280K $0.00 See footnotes F1, F2, F3
transaction AMAM ADSs Purchase $23.5M +3.62M +47.01% $6.50 11.3M Mar 6, 2023 Ordinary Shares 25.3M $0.00 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each ADS represents 7 ordinary shares, par value $0.0001 per share ("Ordinary Shares").
F2 Securities held for the accounts of certain investment funds and accounts for which Darwin Global Management, Ltd. ("Darwin Global") acts as investment manager, including Darwin Global Master Fund, Ltd. ("Master Fund"). The sole shareholder of Darwin Global is controlled by Dr. Abhishek Trehan ("Dr. Trehan").
F3 For purposes of Section 16 of the Securities Exchange Act of 1934, each of Darwin Global, Master Fund and Dr. Trehan expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that any of Darwin Global, Master Fund or Dr. Trehan is the beneficial owner of such securities for purposes of Section 16 or any other purpose.